Non-Current Assets
Investments - Amortized Cost Basis
Moderna Investments - Amortized Cost Basis increased by 0.4% to $5.56B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.0%, from $6.78B to $5.56B. Over 5 years (FY 2020 to FY 2025), Investments - Amortized Cost Basis shows an upward trend with a 16.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ1 2018
Last reportedQ1 2026May 1, 2026
Metric ID:
investments_amortized_costHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.60B | $9.81B | $0.00 | $30.00M | $30.00M | $30.00M | $42.00M | $42.00M | $42.00M | $42.00M | $42.00M | $42.00M | $42.00M | $7.58B | $7.61B | $6.78B | $6.23B | $5.51B | $5.53B | $5.56B |
| QoQ Change | — | +48.6% | -100.0% | — | +0.0% | +0.0% | +40.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | >999% | +0.5% | -11.0% | -8.1% | -11.5% | +0.4% | +0.4% |
| YoY Change | — | — | — | — | -99.5% | -99.7% | — | +40.0% | +40.0% | +40.0% | +0.0% | +0.0% | +0.0% | >999% | >999% | >999% | >999% | -27.3% | -27.3% | -18.0% |
Range$0.00 – $9.81B
CAGR-3.6%
Avg YoY Growth>999%
Median YoY Growth+0.0%
Current Streak2 quarters growth
Investments - Amortized Cost Basis at Other Companies
Frequently Asked Questions
- What is Moderna's investments - amortized cost basis?
- Moderna (MRNA) reported investments - amortized cost basis of $5.56B in Q1 2026.
- How has Moderna's investments - amortized cost basis changed year-over-year?
- Moderna's investments - amortized cost basis decreased by 18.0% year-over-year, from $6.78B to $5.56B.
- What is the long-term trend for Moderna's investments - amortized cost basis?
- Over 5 years (2020 to 2025), Moderna's investments - amortized cost basis has grown at a 16.1% compound annual growth rate (CAGR), from $2.62B to $5.53B.